Take a look at this article, over 4 years old now and not sure how much is still relevant, but still an interesting read. Prostate, breast, leukaemia and others mentioned.
http://www.news-medical.net/news/20...for-its-anti-cancer-antibody-therapeutic.aspx
Very easy mistake to misread emails but ALL oncology indications is quite a statement.
For the uneducated like myself, Oncology is the branch of medicine that deals with tumors and cancers.
So Hefei are looking to develop and commercialise PAT-SC1 for ALL cancers in China. As I said earlier, quite a statement!
Is something up?, page-60
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $10.97K | 3.626M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 31554019 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 27089307 | 15 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |